David J. Gullen
Director/Board Member at Translational Genomics Research Institute
Profile
David J.
Gullen is currently the Director at the Translational Genomics Research Institute and the Director at the Flinn Foundation.
He has a graduate degree from Arizona State University, an undergraduate degree from Princeton University, and a doctorate degree from the University of Arizona.
David J. Gullen active positions
Companies | Position | Start |
---|---|---|
Translational Genomics Research Institute
Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Director/Board Member | - |
Flinn Foundation
Flinn Foundation Investment Trusts/Mutual FundsMiscellaneous Flinn Foundation engages as a philanthropic grantmaking organization. It helps in the advancement of the state's bioscience sector and provides education to high-achieving students at an Arizona public university. The company was founded by Robert S. Finn and Irene Flinn in 1965 and is headquartered in Phoenix, AZ. | Director/Board Member | 2023-03-29 |
Training of David J. Gullen
University of Arizona | Doctorate Degree |
Arizona State University | Graduate Degree |
Princeton University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Translational Genomics Research Institute
Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Commercial Services |
Flinn Foundation
Flinn Foundation Investment Trusts/Mutual FundsMiscellaneous Flinn Foundation engages as a philanthropic grantmaking organization. It helps in the advancement of the state's bioscience sector and provides education to high-achieving students at an Arizona public university. The company was founded by Robert S. Finn and Irene Flinn in 1965 and is headquartered in Phoenix, AZ. | Miscellaneous |
- Stock Market
- Insiders
- David J. Gullen